The new facility will further strengthen Ion Exchange India’s Chemicals, Resins and Membranes business in India and globally
Hyderabad, August 09, 2019: Leaders in water and environment management solutions, Ion Exchange (India) Limited, today announces the launch of its new Research & Development Centre at Patancheru in Telangana. The centre will focus on the company’s Chemicals, Resins and Membranes business. It will also provide technical and scientific support to the company’s existing technology and engineering segments for designing new processes and products.
With an investment of around INR 300 million, the R&D Centre will develop new resins, membranes, polymers and speciality chemical technologies related to water, waste water treatment, process separation and purification, speciality process application and catalysis. The microbiology lab within the centre will lay emphasis on enzyme research and application specifically for the textile and food & beverage industry. Many of these products will be import substitutes with very large potential for enhancing the company’s exports.
Speaking during the inauguration of the R&D centre, Mr. Rajesh Sharma, Chairman and Managing Director, Ion Exchange (India) Limited said, “Ion Exchange has been in the forefront of R&D in water and waste water management since 1965. Being pioneers in this industry we have been investing a significant portion of our revenues in research and new technology development thereby maintaining our leadership in markets we serve. Our new R&D centre which is an expansion of our current research and development facility in Hyderabad and Navi Mumbai and will provide an impetus to enhance our competitiveness not only in India but globally. Through our innovations and R&D initiatives we will continue to ‘Make in India’ cutting edge sustainable solutions for industries, institutions, homes and communities”.
With continued innovations, the new R&D centre will offer newer solutions to Ion Exchange customers in India and across geographies it serves.
Corporate Comm India (CCI Newswire)
· World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…
Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Winter weather brings a host…
By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…
Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…
Coimbatore, October 30, 2024: Sri Ramakrishna Hospital’s Neurology experts observes “World Stroke Day” on October…